On Monday shares of Staples, Inc. (NASDAQ:SPLS) closed at $16.70. Company’s sales growth for last 5 years was -1.50% and EPS growth for next 5 years is recorded as -1.78%. Announced March 26, that Staples, Inc. (NASDAQ:SPLS) anada is making more 3D printing happen by offering the latest 3D products and services in this rapidly growing area. The Afinia H-Series H480 3D Printer is now available on staples.ca and in 10 stores across British Columbia and Alberta.
American International Group, Inc. (NYSE:AIG) in last trading activity increased 1.20% to close at $54.68. Company weekly performance is -2.06% while its quarterly performance stands at -2.86%. American International Group, Inc. (NYSE:AIG) is -3.55% away from its 52 week high. Robert S. “Steve” Miller intends to step down in July as chairman of American International Group, Inc. (NYSE:AIG) after five years in the role, a person familiar with the matter said Monday. AIG directors haven’t yet decided on a replacement, but the next outside chairman is expected to be a current board member, this person added.
On last trading day Novartis AG (NYSE:NVS) increased 0.91% to close at $101.31. Its volatility for the week is 1.26% while volatility for the month is 1.16%. NVS’s sales growth for past 5 years was 3.50% and its EPS growth for past 5 years was 3.20%. Novartis AG (NYSE:NVS) monthly performance is 1.74%. Novartis (NYSE:NVS) announced that the US Food and Drug Administration (FDA) has approved Jadenu (deferasirox) tablets, a new oral formulation of Exjade (deferasirox) tablets for oral suspension, for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes or NTDT in patients 10 years of age and older.
Actavis plc (NYSE:ACT) has 0.20% insider ownership while its institutional ownership stands at 62.70%. In last trading activity company’s stock closed at $304.76. Amneal Pharmaceuticals Pty Ltd and Actavis Australia Pty Ltd, a subsidiary of Actavis plc (NYSE: ACT), announced they have signed a binding letter of intent which provides that Amneal intends to acquire substantially all of Actavis’ in-country generic pharmaceuticals business for an agreed price, subject to completion of confirmatory due diligence and definitive agreements.
On last trading day Agilent Technologies Inc. (NYSE:A) increased 1.48% to close at $41.72. Its volatility for the week is 1.85% while volatility for the month is 1.45%. A’s sales growth for past 5 years was 9.30% and its EPS growth for past 5 years was 79.30%. Agilent Technologies Inc. (NYSE:A) monthly performance is -0.93%. Rigaku Corp. and Agilent Technologies Inc. (NYSE:A) announced an agreement for Rigaku, a privately held scientific instrumentation company headquartered in Tokyo, to acquire Agilent’s X-ray diffraction (XRD) business.